10173 Long-Term Therapy of Elagolix + Add-Back Therapy in Women with Endometriosis-Associated Pain for 48 Months: Update on Bone Mineral Density

In: Journal of Minimally Invasive Gynecology · 2023 · vol. 30(11) , pp. S105 · doi:10.1016/j.jmig.2023.08.336 · W4388206533
article OA: bronze CC0
AI-generated summary by claude@2026-06, 2026-06-12

This study assessed the long-term safety and efficacy of elagolix plus add-back therapy for endometriosis-associated pain over 48 months, focusing on bone mineral density changes.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK